Drug intelligence / Profile preview

liprodicaine

Development stage: Preclinical
Lead developer: The Second Xiangya Hospital
Modality: Small Molecules
Administration: Topical

Overview

Liprodicaine is a drug formulated as a cream, currently under investigation for its use as a local anesthetic during dermatological procedures. Clinical trials are comparing its safety and efficacy to lidocaine cream for treatments such as facial freckle removal and dot matrix laser procedures, suggesting a similar function in providing topical anesthesia.

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on liprodicaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on liprodicaine.

Explore the full profile